Chemed (NYSE:CHE) Updates FY 2025 Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 24.950-25.450 for the period, compared to the consensus estimate of 24.890. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CHE shares. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. StockNews.com lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday.

Chemed Stock Up 2.4 %

CHE traded up $13.80 during trading hours on Friday, reaching $599.92. 18,293 shares of the company’s stock traded hands, compared to its average volume of 92,964. The firm has a 50-day moving average price of $545.15 and a 200 day moving average price of $563.27. The firm has a market capitalization of $9.03 billion, a PE ratio of 30.42, a PEG ratio of 2.15 and a beta of 0.48. Chemed has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s dividend payout ratio (DPR) is presently 10.11%.

Insider Activity at Chemed

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the stock in a transaction dated Monday, December 30th. The stock was purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.32% of the stock is currently owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.